Skip to content

Effects of a Common Cold Treatment on Cognitive Function

Effects of a Common Cold Treatment on Cognitive Function

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01466348
Enrollment
72
Registered
2011-11-07
Start date
2011-02-28
Completion date
2011-04-30
Last updated
2013-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common Cold

Keywords

Paracetomol, Caffeine, Common cold

Brief summary

A reduction in alertness and lower levels of performance are commonly associated with the common cold. Paracetamol has been shown to be more effective than placebo in treating symptoms associated with upper respiratory tract infection; caffeine has been shown to increase levels of alertness and improve performance of people suffering from colds. This study will investigate any improvement in alertness and performance based on cognitive function and mood assessment in subjects suffering from the common cold, when taking a novel paracetamol and caffeine combination verses paracetamol alone.

Interventions

Paracetamol 1000 mg and caffeine 130 mg

DRUGParacetamol

Paracetamol 1000 mg

Sponsors

GlaxoSmithKline
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Present with symptoms of the common cold of no more than 96 hours duration * Score of 2 or more on a self-rating for malaise and at least 4 other cold symptoms

Exclusion criteria

* Pregnancy or lactation * Hypersensitivity to drugs * Have taken caffeine in the last 12 hours or treated their cold

Design outcomes

Primary

MeasureTime frameDescription
Adjusted Mean Change From Baseline in Number of Valid Responses to Rapid Visual Information Processing (RVIP) Cognitive TestBaseline to 30 minutes post treatment administrationThe RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. The test lasted approximately 9 minutes and mean number of valid responses to stimulus was calculated.

Secondary

MeasureTime frameDescription
Adjusted Mean Change in Baseline in Valid Reaction Time to RVIP Cognitive TestBaseline, 30 minutes and up to 60 minutes post treatment administrationThe RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. Mean valid reaction time was determined.
Mean Change From Baseline in Number of Incorrect and Missed Responses to RVIP Cognitive TestBaseline, 30 minutes and up to 60 minutes post treatment administrationThe RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. The test lasted approximately 9 minutes and mean number of valid responses to stimulus was calculated.
Adjusted Mean Change From Baseline in Number of Valid Responses to Sustained Attention Tasks (SAT) Cognitive TestBaseline, 30 minutes and up to 60 minutes post treatment administrationAuditory and visual attention of participants was evaluated using a validated Sustained Attention task. For the sustained visual attention task, participants were required to respond to the letter 's' every time it appears in a continuous stream of letters presented on a screen. For the sustained auditory attention task, participants responded to the number '8' every time it appears in a continuous stream of numbers presented through headphones. Total test duration was approximately 6 minutes. Mean values of valid responses to visual and auditory tests were calculated.
Mean Change From Baseline in Number of Incorrect and Missed Responses to SAT Cognitive TestBaseline, 30 minutes and up to 60 minutes post treatment administrationAuditory and visual attention of participants was evaluated using a validated Sustained Attention task. For the sustained visual attention task, participants were required to respond to the letter 's' every time it appears in a continuous stream of letters presented on a screen. For the sustained auditory attention task, participants responded to the number '8' every time it appears in a continuous stream of numbers presented through headphones. Total test duration was approximately 6 minutes. Mean values of incorrect and missed responses to visual and auditory tests were calculated.
Adjusted Mean Change From Baseline in Number of Valid Responses to RVIP Cognitive TestBaseline to 60 minutes post treatment administrationThe RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. The test lasted approximately 9 minutes and mean number of valid responses to stimulus was calculated.
Adjusted Mean Change From Baseline in Number of Valid Responses to Divided Attention Task (DAT) Cognitive TestBaseline, 30 minutes and up to 60 minutes post treatment administrationFor the DAT Cognitive test, auditory and visual stimuli were simultaneously presented and participants were asked to respond to occurrences of 's' (visual) or '8' (auditory). Total test duration was approximately 6 minutes. Mean values of valid responses to visual and auditory tests were calculated.
Adjusted Mean Change From Baseline in Valid Reaction Time to DAT Cognitive TestBaseline, 30 minutes and up to 60 minutes post treatment administrationFor the DAT Cognitive test, auditory and visual stimuli were simultaneously presented and participants were asked to respond to occurrences of 's' (visual) or '8' (auditory). Total test duration was approximately 6 minutes. Mean values of valid reaction time to visual and auditory tests were calculated.
Mean Change From Baseline in Number of Incorrect and Missed Responses to DAT Cognitive TestBaseline, 30 minutes and up to 60 minutes post treatment administrationFor the DAT Cognitive test, auditory and visual stimuli were simultaneously presented and participants were asked to respond to occurrences of 's' (visual) or '8' (auditory). Total test duration was approximately 6 minutes. Mean values of incorrect and missed responses to visual and auditory tests were calculated.
Adjusted Mean Change From Baseline in Mood Alertness and Physical Sensation Scales (MAPSS) Cognitive TestBaseline, 30 minutes and up to 60 minutes post treatment administrationMood patterns was evaluated using the Mood, Alertness and Physical Sensation Scales (MAPSS) which comprised of 23 questions describing moods and physical sensations, on a 9-point scale anchored at the left hand end with 'not at all' and the right hand end with 'extremely'. For each question, '9' represented the 'best' score and '1' represented the 'worst' score. Mean score was calculated by summing the responses and dividing by the number of questions answered. MAPSS Questionnaire was further divided into three main clusters: Alertness; Anxiety and Headache as per the questions.
Adjusted Mean Change From Baseline in Valid Reaction Time to SAT Cognitive TestBaseline, 30 minutes and up to 60 minutes post treatment administrationAuditory and visual attention of participants was evaluated using a validated Sustained Attention task. For the sustained visual attention task, participants were required to respond to the letter 's' every time it appears in a continuous stream of letters presented on a screen. For the sustained auditory attention task, participants responded to the number '8' every time it appears in a continuous stream of numbers presented through headphones. Total test duration was approximately 6 minutes. Mean values of valid reaction time to visual and auditory tests were calculated.

Countries

United Kingdom

Participant flow

Recruitment details

Participants were recruited at the clinical site.

Pre-assignment details

A total of 75 participants were screened, and 72 were randomized. 3 participants did not meet the study criterion. A 5 hour washout period was maintained between treatment periods.

Participants by arm

ArmCount
All Randomized Participants
All randomized participants were evaluated for baseline measures.
71
Total71

Withdrawals & dropouts

PeriodReasonFG000FG001
Period I - First InterventionWithdrawal by Subject01

Baseline characteristics

CharacteristicAll Randomized Participants
Age Continuous20.8 Years
STANDARD_DEVIATION 4.19
Sex: Female, Male
Female
47 Participants
Sex: Female, Male
Male
24 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 710 / 71
serious
Total, serious adverse events
0 / 710 / 71

Outcome results

Primary

Adjusted Mean Change From Baseline in Number of Valid Responses to Rapid Visual Information Processing (RVIP) Cognitive Test

The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. The test lasted approximately 9 minutes and mean number of valid responses to stimulus was calculated.

Time frame: Baseline to 30 minutes post treatment administration

Population: Intent-To-Treat (ITT) population: All randomized participants who were randomized and had at least one post-baseline efficacy evaluation.

ArmMeasureValue (MEAN)Dispersion
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Number of Valid Responses to Rapid Visual Information Processing (RVIP) Cognitive Test4.8 Valid responsesStandard Deviation 0.8
Paracetamol PowderAdjusted Mean Change From Baseline in Number of Valid Responses to Rapid Visual Information Processing (RVIP) Cognitive Test1.3 Valid responsesStandard Deviation 0.8
Comparison: Null hypothesis was no difference in treatments in the change from baseline in the number of valid responses from the RVIP.p-value: 0.000895% CI: [1.5, 5.6]ANOVA
Secondary

Adjusted Mean Change From Baseline in Mood Alertness and Physical Sensation Scales (MAPSS) Cognitive Test

Mood patterns was evaluated using the Mood, Alertness and Physical Sensation Scales (MAPSS) which comprised of 23 questions describing moods and physical sensations, on a 9-point scale anchored at the left hand end with 'not at all' and the right hand end with 'extremely'. For each question, '9' represented the 'best' score and '1' represented the 'worst' score. Mean score was calculated by summing the responses and dividing by the number of questions answered. MAPSS Questionnaire was further divided into three main clusters: Alertness; Anxiety and Headache as per the questions.

Time frame: Baseline, 30 minutes and up to 60 minutes post treatment administration

Population: ITT population: All randomized participants who were randomized and had at least one post-baseline efficacy evaluation.

ArmMeasureGroupValue (MEAN)Dispersion
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Mood Alertness and Physical Sensation Scales (MAPSS) Cognitive TestAlertness at 30 minutes0.8 Score on a scaleStandard Error 0.12
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Mood Alertness and Physical Sensation Scales (MAPSS) Cognitive TestAlertness at 60 minutes0.7 Score on a scaleStandard Error 0.13
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Mood Alertness and Physical Sensation Scales (MAPSS) Cognitive TestAnxiety at 30 minutes0.2 Score on a scaleStandard Error 0.08
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Mood Alertness and Physical Sensation Scales (MAPSS) Cognitive TestAnxiety at 60 minutes0.3 Score on a scaleStandard Error 0.08
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Mood Alertness and Physical Sensation Scales (MAPSS) Cognitive TestHeadache at 30 minutes0.4 Score on a scaleStandard Error 0.1
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Mood Alertness and Physical Sensation Scales (MAPSS) Cognitive TestHeadache at 60 minutes0.6 Score on a scaleStandard Error 0.1
Paracetamol PowderAdjusted Mean Change From Baseline in Mood Alertness and Physical Sensation Scales (MAPSS) Cognitive TestHeadache at 30 minutes0.4 Score on a scaleStandard Error 0.1
Paracetamol PowderAdjusted Mean Change From Baseline in Mood Alertness and Physical Sensation Scales (MAPSS) Cognitive TestAlertness at 30 minutes0.2 Score on a scaleStandard Error 0.12
Paracetamol PowderAdjusted Mean Change From Baseline in Mood Alertness and Physical Sensation Scales (MAPSS) Cognitive TestAnxiety at 60 minutes0.4 Score on a scaleStandard Error 0.08
Paracetamol PowderAdjusted Mean Change From Baseline in Mood Alertness and Physical Sensation Scales (MAPSS) Cognitive TestAlertness at 60 minutes0.1 Score on a scaleStandard Error 0.13
Paracetamol PowderAdjusted Mean Change From Baseline in Mood Alertness and Physical Sensation Scales (MAPSS) Cognitive TestHeadache at 60 minutes0.6 Score on a scaleStandard Error 0.1
Paracetamol PowderAdjusted Mean Change From Baseline in Mood Alertness and Physical Sensation Scales (MAPSS) Cognitive TestAnxiety at 30 minutes0.2 Score on a scaleStandard Error 0.08
Secondary

Adjusted Mean Change From Baseline in Number of Valid Responses to Divided Attention Task (DAT) Cognitive Test

For the DAT Cognitive test, auditory and visual stimuli were simultaneously presented and participants were asked to respond to occurrences of 's' (visual) or '8' (auditory). Total test duration was approximately 6 minutes. Mean values of valid responses to visual and auditory tests were calculated.

Time frame: Baseline, 30 minutes and up to 60 minutes post treatment administration

Population: ITT population: All randomized participants who were randomized and had at least one post-baseline efficacy evaluation.

ArmMeasureGroupValue (MEAN)Dispersion
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Number of Valid Responses to Divided Attention Task (DAT) Cognitive Test30 minutes6.8 Valid responsesStandard Error 1
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Number of Valid Responses to Divided Attention Task (DAT) Cognitive Test60 minutes7.4 Valid responsesStandard Error 1.01
Paracetamol PowderAdjusted Mean Change From Baseline in Number of Valid Responses to Divided Attention Task (DAT) Cognitive Test30 minutes2.0 Valid responsesStandard Error 0.99
Paracetamol PowderAdjusted Mean Change From Baseline in Number of Valid Responses to Divided Attention Task (DAT) Cognitive Test60 minutes1.9 Valid responsesStandard Error 1
Secondary

Adjusted Mean Change From Baseline in Number of Valid Responses to RVIP Cognitive Test

The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. The test lasted approximately 9 minutes and mean number of valid responses to stimulus was calculated.

Time frame: Baseline to 60 minutes post treatment administration

Population: ITT population: All randomized participants who were randomized and had at least one post-baseline efficacy evaluation.

ArmMeasureValue (MEAN)Dispersion
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Number of Valid Responses to RVIP Cognitive Test7.1 Valid responsesStandard Deviation 0.93
Paracetamol PowderAdjusted Mean Change From Baseline in Number of Valid Responses to RVIP Cognitive Test0.6 Valid responsesStandard Deviation 0.93
Comparison: Null hypothesis was no difference in treatments in the change from baseline in the number of valid responses from the RVIP.p-value: <0.000195% CI: [4.5, 8.4]ANOVA
Secondary

Adjusted Mean Change From Baseline in Number of Valid Responses to Sustained Attention Tasks (SAT) Cognitive Test

Auditory and visual attention of participants was evaluated using a validated Sustained Attention task. For the sustained visual attention task, participants were required to respond to the letter 's' every time it appears in a continuous stream of letters presented on a screen. For the sustained auditory attention task, participants responded to the number '8' every time it appears in a continuous stream of numbers presented through headphones. Total test duration was approximately 6 minutes. Mean values of valid responses to visual and auditory tests were calculated.

Time frame: Baseline, 30 minutes and up to 60 minutes post treatment administration

Population: ITT population: All randomized participants who were randomized and had at least one post-baseline efficacy evaluation.

ArmMeasureGroupValue (MEAN)Dispersion
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Number of Valid Responses to Sustained Attention Tasks (SAT) Cognitive Test30 minutes1.8 Valid responsesStandard Error 0.52
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Number of Valid Responses to Sustained Attention Tasks (SAT) Cognitive Test60 minutes1.5 Valid responsesStandard Error 0.55
Paracetamol PowderAdjusted Mean Change From Baseline in Number of Valid Responses to Sustained Attention Tasks (SAT) Cognitive Test60 minutes-0.7 Valid responsesStandard Error 0.55
Paracetamol PowderAdjusted Mean Change From Baseline in Number of Valid Responses to Sustained Attention Tasks (SAT) Cognitive Test30 minutes-0.5 Valid responsesStandard Error 0.51
Secondary

Adjusted Mean Change From Baseline in Valid Reaction Time to DAT Cognitive Test

For the DAT Cognitive test, auditory and visual stimuli were simultaneously presented and participants were asked to respond to occurrences of 's' (visual) or '8' (auditory). Total test duration was approximately 6 minutes. Mean values of valid reaction time to visual and auditory tests were calculated.

Time frame: Baseline, 30 minutes and up to 60 minutes post treatment administration

Population: ITT population: All randomized participants who were randomized and had at least one post-baseline efficacy evaluation.

ArmMeasureGroupValue (MEAN)Dispersion
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Valid Reaction Time to DAT Cognitive Test30 Minutes1.65 msecStandard Error 2.1
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Valid Reaction Time to DAT Cognitive Test60 minutes-5.49 msecStandard Error 2.44
Paracetamol PowderAdjusted Mean Change From Baseline in Valid Reaction Time to DAT Cognitive Test30 Minutes-7.42 msecStandard Error 2.07
Paracetamol PowderAdjusted Mean Change From Baseline in Valid Reaction Time to DAT Cognitive Test60 minutes-12.39 msecStandard Error 2.43
Secondary

Adjusted Mean Change From Baseline in Valid Reaction Time to SAT Cognitive Test

Auditory and visual attention of participants was evaluated using a validated Sustained Attention task. For the sustained visual attention task, participants were required to respond to the letter 's' every time it appears in a continuous stream of letters presented on a screen. For the sustained auditory attention task, participants responded to the number '8' every time it appears in a continuous stream of numbers presented through headphones. Total test duration was approximately 6 minutes. Mean values of valid reaction time to visual and auditory tests were calculated.

Time frame: Baseline, 30 minutes and up to 60 minutes post treatment administration

Population: ITT population: All randomized participants who were randomized and had at least one post-baseline efficacy evaluation.

ArmMeasureGroupValue (MEAN)Dispersion
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Valid Reaction Time to SAT Cognitive Test30 minutes-6.49 msecStandard Error 2.8
Paracetamol/ Caffeine TabletAdjusted Mean Change From Baseline in Valid Reaction Time to SAT Cognitive Test60 minutes-10.69 msecStandard Error 3.12
Paracetamol PowderAdjusted Mean Change From Baseline in Valid Reaction Time to SAT Cognitive Test30 minutes-6.18 msecStandard Error 2.75
Paracetamol PowderAdjusted Mean Change From Baseline in Valid Reaction Time to SAT Cognitive Test60 minutes-9.45 msecStandard Error 3.1
Secondary

Adjusted Mean Change in Baseline in Valid Reaction Time to RVIP Cognitive Test

The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. Mean valid reaction time was determined.

Time frame: Baseline, 30 minutes and up to 60 minutes post treatment administration

Population: ITT population: All randomized participants who were randomized and had at least one post-baseline efficacy evaluation.

ArmMeasureGroupValue (MEAN)Dispersion
Paracetamol/ Caffeine TabletAdjusted Mean Change in Baseline in Valid Reaction Time to RVIP Cognitive Test30 minutes6.00 milliseconds (msec)Standard Error 3.916
Paracetamol/ Caffeine TabletAdjusted Mean Change in Baseline in Valid Reaction Time to RVIP Cognitive Test60 minutes0.08 milliseconds (msec)Standard Error 3.983
Paracetamol PowderAdjusted Mean Change in Baseline in Valid Reaction Time to RVIP Cognitive Test30 minutes1.88 milliseconds (msec)Standard Error 3.916
Paracetamol PowderAdjusted Mean Change in Baseline in Valid Reaction Time to RVIP Cognitive Test60 minutes-4.85 milliseconds (msec)Standard Error 3.954
Secondary

Mean Change From Baseline in Number of Incorrect and Missed Responses to DAT Cognitive Test

For the DAT Cognitive test, auditory and visual stimuli were simultaneously presented and participants were asked to respond to occurrences of 's' (visual) or '8' (auditory). Total test duration was approximately 6 minutes. Mean values of incorrect and missed responses to visual and auditory tests were calculated.

Time frame: Baseline, 30 minutes and up to 60 minutes post treatment administration

Population: ITT population: All randomized participants who were randomized and had at least one post-baseline efficacy evaluation.

ArmMeasureGroupValue (MEAN)Dispersion
Paracetamol/ Caffeine TabletMean Change From Baseline in Number of Incorrect and Missed Responses to DAT Cognitive TestIncorrect responses at 30 minutes-5.4 ResponsesStandard Error 0.83
Paracetamol/ Caffeine TabletMean Change From Baseline in Number of Incorrect and Missed Responses to DAT Cognitive TestIncorrect responses at 60 minutes-5.2 ResponsesStandard Error 0.77
Paracetamol/ Caffeine TabletMean Change From Baseline in Number of Incorrect and Missed Responses to DAT Cognitive TestMissed responses at 30 minutes-6.7 ResponsesStandard Error 1.19
Paracetamol/ Caffeine TabletMean Change From Baseline in Number of Incorrect and Missed Responses to DAT Cognitive TestMissed responses at 60 minutes-7.4 ResponsesStandard Error 1.24
Paracetamol PowderMean Change From Baseline in Number of Incorrect and Missed Responses to DAT Cognitive TestMissed responses at 60 minutes-1.9 ResponsesStandard Error 0.75
Paracetamol PowderMean Change From Baseline in Number of Incorrect and Missed Responses to DAT Cognitive TestIncorrect responses at 30 minutes-1.4 ResponsesStandard Error 0.83
Paracetamol PowderMean Change From Baseline in Number of Incorrect and Missed Responses to DAT Cognitive TestMissed responses at 30 minutes-2.0 ResponsesStandard Error 0.83
Paracetamol PowderMean Change From Baseline in Number of Incorrect and Missed Responses to DAT Cognitive TestIncorrect responses at 60 minutes-0.2 ResponsesStandard Error 0.92
Secondary

Mean Change From Baseline in Number of Incorrect and Missed Responses to RVIP Cognitive Test

The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. The test lasted approximately 9 minutes and mean number of valid responses to stimulus was calculated.

Time frame: Baseline, 30 minutes and up to 60 minutes post treatment administration

Population: ITT population: All randomized participants who were randomized and had at least one post-baseline efficacy evaluation.

ArmMeasureGroupValue (MEAN)Dispersion
Paracetamol/ Caffeine TabletMean Change From Baseline in Number of Incorrect and Missed Responses to RVIP Cognitive TestMissed responses at 30 minutes-4.8 ResponsesStandard Error 0.69
Paracetamol/ Caffeine TabletMean Change From Baseline in Number of Incorrect and Missed Responses to RVIP Cognitive TestIncorrect responses at 30 minutes-2.3 ResponsesStandard Error 1.57
Paracetamol/ Caffeine TabletMean Change From Baseline in Number of Incorrect and Missed Responses to RVIP Cognitive TestMissed responses at 60 minutes-7.1 ResponsesStandard Error 0.9
Paracetamol/ Caffeine TabletMean Change From Baseline in Number of Incorrect and Missed Responses to RVIP Cognitive TestIncorrect responses at 60 minutes-1.7 ResponsesStandard Error 1.93
Paracetamol PowderMean Change From Baseline in Number of Incorrect and Missed Responses to RVIP Cognitive TestMissed responses at 60 minutes-0.6 ResponsesStandard Error 1
Paracetamol PowderMean Change From Baseline in Number of Incorrect and Missed Responses to RVIP Cognitive TestIncorrect responses at 30 minutes-2.7 ResponsesStandard Error 1.52
Paracetamol PowderMean Change From Baseline in Number of Incorrect and Missed Responses to RVIP Cognitive TestMissed responses at 30 minutes-1.3 ResponsesStandard Error 0.89
Paracetamol PowderMean Change From Baseline in Number of Incorrect and Missed Responses to RVIP Cognitive TestIncorrect responses at 60 minutes-2.7 ResponsesStandard Error 1.8
Secondary

Mean Change From Baseline in Number of Incorrect and Missed Responses to SAT Cognitive Test

Auditory and visual attention of participants was evaluated using a validated Sustained Attention task. For the sustained visual attention task, participants were required to respond to the letter 's' every time it appears in a continuous stream of letters presented on a screen. For the sustained auditory attention task, participants responded to the number '8' every time it appears in a continuous stream of numbers presented through headphones. Total test duration was approximately 6 minutes. Mean values of incorrect and missed responses to visual and auditory tests were calculated.

Time frame: Baseline, 30 minutes and up to 60 minutes post treatment administration

Population: ITT population: All randomized participants who were randomized and had at least one post-baseline efficacy evaluation.

ArmMeasureGroupValue (MEAN)Dispersion
Paracetamol/ Caffeine TabletMean Change From Baseline in Number of Incorrect and Missed Responses to SAT Cognitive TestIncorrect responses at 30 minutes-2.3 ResponsesStandard Error 0.63
Paracetamol/ Caffeine TabletMean Change From Baseline in Number of Incorrect and Missed Responses to SAT Cognitive TestIncorrect responses at 60 minutes-3.6 ResponsesStandard Error 0.71
Paracetamol/ Caffeine TabletMean Change From Baseline in Number of Incorrect and Missed Responses to SAT Cognitive TestMissed responses at 60 minutes-1.5 ResponsesStandard Error 0.54
Paracetamol/ Caffeine TabletMean Change From Baseline in Number of Incorrect and Missed Responses to SAT Cognitive TestMissed responses at 30 minutes-1.8 ResponsesStandard Error 0.59
Paracetamol PowderMean Change From Baseline in Number of Incorrect and Missed Responses to SAT Cognitive TestMissed responses at 60 minutes0.7 ResponsesStandard Error 0.55
Paracetamol PowderMean Change From Baseline in Number of Incorrect and Missed Responses to SAT Cognitive TestIncorrect responses at 30 minutes0.1 ResponsesStandard Error 0.65
Paracetamol PowderMean Change From Baseline in Number of Incorrect and Missed Responses to SAT Cognitive TestIncorrect responses at 60 minutes0.6 ResponsesStandard Error 0.72
Paracetamol PowderMean Change From Baseline in Number of Incorrect and Missed Responses to SAT Cognitive TestMissed responses at 30 minutes0.5 ResponsesStandard Error 0.44

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026